Positive regulation of immune effector process

pathway activity — cross-omics
GO:0002699Cross-omicsPROTEIN-MS → RNAPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, RNA activity of the Positive regulation of immune effector process pathway is significantly associated with the RNA expression of multiple genes, with the BRCA cohort showing a particularly strong set of associations.

The most reproducible pathway-associated genes across cancer lineages are PLA1A, KRT34, and LDHD, each associated with the pathway in up to 2 cancer types. Since the analysis shows associations rather than directional relationships, both pathway-to-partner and partner-to-pathway views are reported.

Each partner is linked to its corresponding Q-omics profile. The scatter plot shows the strongest association, Positive regulation of immune effector process activity versus PLA1A in BRCA (Pearson r = -0.19).

Pathway-associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (pathway→partner) and Y-score (partner→pathway) are standardized regression coefficients; both directions are reported because the association is undirected. The reported p-values are derived from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
BRCAPLA1A →-0.985-0.240.008.00732
OVKRT34 →+0.084+0.210.003.00131
OVLDHD →-2.061-0.238<.001.00531
OVAHCYL1 →+0.726+0.229.002.00131
OVRGPD4 →+0.390+0.181.002.00331
OVZNF675 →-0.708-0.213.008<.00131
Each partner links to its Q-omics profile. Showing the 6 strongest associations by consensus.

GO:0002699 vs PLA1A — BRCA

Per-sample scatter of Positive regulation of immune effector process activity vs PLA1A in BRCA.

Explore this scatter interactively →

Exploration